Loading cancer entity…
Loading cancer entity…
Clinical trials
79 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06010277 | Folinic Acid for Prevention of Pemetrexed-induced Toxicity(FLEX) | unknown | Phase 4 | 50 | Amphia HospitalOTHER | 1 | Aug 24, 2023 | clinicaltrials |
| NCT04554524 | Chemotherapy Combined With Pembrolizumab in Treating Patients With Thymoma and Thymic Carcinoma | unknown | Phase 4 | 40 | Tang-Du HospitalOTHER | 1 | Oct 28, 2020 | clinicaltrials |
Showing 1–2 of 2 studies
Data updated 22 days agoSource updated Aug 24, 2023source: clinicaltrials